UNIPHAR PLC (UPR.I) Stock Price, Forecast & Analysis
Europe - Euronext Dublin - DUB:UPR - IE00BJ5FQX74 - Common Stock
UPR.I Key Statistics, Chart & Performance
The current stock price of UPR.I is 3.72 EUR. In the past month the price decreased by -2.87%. In the past year, price increased by 68.33%.
UPR.I Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| AXNA.DE | AMPLIFON SPA | 25.2 | 3.02B | ||
| AMP.MI | AMPLIFON SPA | 24.98 | 3.00B | ||
| FAGR.BR | FAGRON | 18.16 | 1.57B | ||
| ILM1.DE | MEDIOS AG | 19.78 | 373.47M | ||
| BLC.PA | BASTIDE LE CONFORT MEDICAL | 374.29 | 193.09M | ||
| PRE.MI | PREDICT SPA | 13.67 | 4.57M | ||
| VMED.DE | VIROMED MEDICAL AG | N/A | 72.50M |
Related stock screener links
About UPR.I
Company Profile
Uniphar Plc engages in the provision of services within the pharmaceutical and healthcare sector. The firm is focused on improving access to pharmaco-medical products and therapies. The company operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. Its Uniphar Medtech division provides outsourced services, specifically sales, distribution, and support services to medical device manufacturers. Uniphar Pharma division operates a global business with valued services across the lifecycle of a pharmaceutical product. This division operates through on demand and pharma services business units. Uniphar Supply Chain & Retail division provides both pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons in Ireland. The company operates a network of pharmacies under the Life, Allcare, Hickey’s and McCauleys brands. The company also provides services and support that help independent community pharmacies.
Company Info
UNIPHAR PLC
4045 Kingswood Road, Citywest Business Park
DUBLIN DUBLIN IE
Employees: 3500
Phone: 35314687501
UNIPHAR PLC / UPR.I FAQ
Can you describe the business of UNIPHAR PLC?
Uniphar Plc engages in the provision of services within the pharmaceutical and healthcare sector. The firm is focused on improving access to pharmaco-medical products and therapies. The company operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. Its Uniphar Medtech division provides outsourced services, specifically sales, distribution, and support services to medical device manufacturers. Uniphar Pharma division operates a global business with valued services across the lifecycle of a pharmaceutical product. This division operates through on demand and pharma services business units. Uniphar Supply Chain & Retail division provides both pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons in Ireland. The company operates a network of pharmacies under the Life, Allcare, Hickey’s and McCauleys brands. The company also provides services and support that help independent community pharmacies.
Can you provide the latest stock price for UNIPHAR PLC?
The current stock price of UPR.I is 3.72 EUR.
Does UPR stock pay dividends?
UNIPHAR PLC (UPR.I) has a dividend yield of 0.87%. The yearly dividend amount is currently 0.02.
What is the ChartMill technical and fundamental rating of UPR stock?
UPR.I has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
On which exchange is UPR.I stock listed?
UPR.I stock is listed on the Euronext Dublin exchange.
Would investing in UNIPHAR PLC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on UPR.I.
Who owns UNIPHAR PLC?
You can find the ownership structure of UNIPHAR PLC (UPR.I) on the Ownership tab.
UPR.I Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to UPR.I. When comparing the yearly performance of all stocks, UPR.I is one of the better performing stocks in the market, outperforming 85.54% of all stocks.
UPR.I Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to UPR.I. While UPR.I belongs to the best of the industry regarding profitability, there are concerns on its financial health.
UPR.I Financial Highlights
Over the last trailing twelve months UPR.I reported a non-GAAP Earnings per Share(EPS) of 0.22. The EPS increased by 16.84% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.3% | ||
| ROA | 4.25% | ||
| ROE | 17.78% | ||
| Debt/Equity | 1.21 |
UPR.I Forecast & Estimates
12 analysts have analysed UPR.I and the average price target is 4.93 EUR. This implies a price increase of 32.55% is expected in the next year compared to the current price of 3.72.
For the next year, analysts expect an EPS growth of 13.37% and a revenue growth 7.78% for UPR.I